ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,111Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 277

$1.03M Total Retail Price of All Prescriptions

Rank: 12 out of 277

519 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

4% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 16,483 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 56%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $137 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 808 785 1 8
SIMVASTATIN 709 668 2 5
WARFARIN SODIUM 592 592 3 18
METOPROLOL TARTRATE 591 573 4 13
FAMOTIDINE 584 584 5 33
LEVOTHYROXINE SODIUM 551 545 6 11
AMLODIPINE BESYLATE 463 441 7 7
LISINOPRIL 355 348 8 20
DONEPEZIL HCL 321 321 9 32
OMEPRAZOLE 259 250 10 9
DIVALPROEX SODIUM 247 247 11 78
POTASSIUM CHLORIDE 238 221 12 31
LIDODERM 230 227 13 49
ATORVASTATIN CALCIUM 210 201 14 14
GABAPENTIN 203 197 15 44
LANTUS 199 196 16 57
NAMENDA 197 197 17 51
METFORMIN HCL 195 182 18 15
CLOPIDOGREL 191 177 19 26
ESCITALOPRAM OXALATE 189 189 20 59
METOPROLOL SUCCINATE 172 170 21 23
PREDNISONE 159 153 22 4
MIRTAZAPINE 159 157 22 71
PLAVIX 154 146 24 38
FENTANYL 152 152 S2 25 96
OXYCODONE-ACETAMINOPHEN 150 145 S2 26 37
DIOVAN 136 134 27 24
SERTRALINE HCL 134 134 28 48
NYSTATIN 131 131 29 155
ADVAIR DISKUS 119 109 30 2
NITROGLYCERIN PATCH 118 116 31 106
DIGOXIN 115 115 32 53
ENALAPRIL MALEATE 111 102 33 29
MUPIROCIN 108 106 34 88
CYMBALTA 100 90 35 91
CARBIDOPA-LEVODOPA 99 99 36 103
ALBUTEROL SULFATE 99 98 36 45
CITALOPRAM HBR 97 91 38 73
KLOR-CON M20 97 96 38 102
NOVOLOG 95 94 40 98
OXYBUTYNIN CHLORIDE ER 95 95 40 148
HYDROCHLOROTHIAZIDE 94 94 42 30
ZOLPIDEM TARTRATE 94 94 42 16
DILTIAZEM 24HR CD 92 89 44 146
LATANOPROST 89 89 45 200
LOSARTAN POTASSIUM 89 84 45 35
BRIMONIDINE TARTRATE 89 89 45 200
MELOXICAM 88 87 48 56
NOVOLIN R 87 87 49 204
BUSPIRONE HCL 87 87 49 145
RAMIPRIL 86 70 51 60
LEVOFLOXACIN 85 80 52 36
JANUVIA 85 74 52 50
FINASTERIDE 83 82 54 137
TAMSULOSIN HCL 83 82 54 47
ALENDRONATE SODIUM 83 78 54 52
SILVER SULFADIAZINE 82 82 57 207
IPRATROPIUM-ALBUTEROL 75 75 58 62
CARVEDILOL 74 63 59 28
PANTOPRAZOLE SODIUM 73 71 60 43
GLIPIZIDE 73 68 60 77
ATENOLOL 73 73 60 42
AZITHROMYCIN 68 59 63 12
LACTULOSE 67 67 64 67
POLYETHYLENE GLYCOL 3350 66 66 65 144
KLOR-CON M10 65 65 66 183
CYCLOBENZAPRINE HCL 64 55 R 67 92
PROAIR HFA 63 50 68 3
ISOSORBIDE MONONITRATE ER 62 62 69 68
NEXIUM 61 56 70 21
RISPERIDONE 61 61 70 69
CEPHALEXIN 61 59 70 175
PROCRIT 60 60 73 148
METOLAZONE 60 57 73 160
CLONIDINE HCL 59 59 75 58
AMIODARONE HCL 59 59 75 159
LEXAPRO 58 58 77 235
TRAVATAN Z 57 57 78 239
OLANZAPINE 57 55 78 191
OXYCODONE HCL-ACETAMINOPHEN 57 33 S2 78 100
SANTYL 56 56 81 86
ALLOPURINOL 54 54 82 75
ARANESP 52 52 83 253
CRESTOR 51 46 84 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.